Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils

BACKGROUND: The use of umbilical cord mesenchymal stem cells (UC-MSCs) is a burgeoning method for the treatment of liver cirrhosis. However, the secretory phenotype and regulatory ability of UC-MSCs are easily affected by their microenvironment. Ensuring a specific microenvironment to enhance the UC...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ye, Yao, Jia, Yan, Mengchao, Lin, Yan, Wei, Jiayun, Wang, Haiping, Mao, Yongcui, Liu, Pinyan, Li, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656886/
https://www.ncbi.nlm.nih.gov/pubmed/37980535
http://dx.doi.org/10.1186/s12967-023-04732-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656886/
https://www.ncbi.nlm.nih.gov/pubmed/37980535
http://dx.doi.org/10.1186/s12967-023-04732-0

Ejemplares similares